Enterprise Together with KSC
Nunaps
Finland
Company Overview
Nunap Vision provides visual perceptual learning (VPL) training to treat the visual field caused by brain damage.
Sectors
- Medical and Health IT
Project Summary
- Nunap Vision is a SaMD (Software as a Medical Device) utilizing HMD VR.
Business Model
- Revenue modelB2C software sales
- Key CustomerPatients with visual field defects due to brain lesion
Major Performance
-
Sales
- N/A
-
Investment
- USD 4.6M, [TIPS (2017), CompanyK Partners, KTB Network, K2
- Investment (2019)]
-
Employees
- (2018) 5
- (2019) 11
- (2020) 12
-
Patent
- 13 domestic patent applications,
- 3 domestic patent registrations, 8 overseas PCT patents,
- 3 design patent applications
Overseas Expansion
Stage
Preparing for overseas expansion
Status
Pivotal Clinical Trial (ongoing)
Products / Services
1
1
- Target Country
- Finland
- Date of Establishment
- Nov. 30, 2017
-
- contact@nunaps.com contact@nunaps.com
-
- Website
- www.nunaps.com www.nunaps.com
-
- Location
- Songpa-gu, Seoul
-
- CEO
- Dong-Wha Kang
-
- Founder’s Background
-
- Professor of Neurology and Head of R&BD Group at Asan Medical Center
- Visiting Associate Professor, Harvard Medical School, Massachussets General Hospital, Boston, USA (2010-2011)
- Postdoctoral Fellowship, National Institutes of Health, USA (2001-2003)
- Residency and Fellowship in Neurology, Seoul National University Hospital, Seoul (1994-2001)